Transforming Growth Factor-β1 Inhibits Vascular Permeability Factor Release by T Cells in Normal Subjects and in Patients with Minimal-Change Nephrotic Syndrome

Publisher： Karger

E-ISSN： 2235-3186|87|2|111-117

ISSN： 1660-8151

Source： Nephron, Vol.87, Iss.2, 2001-02, pp. : 111-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Interleukin-15 on Vascular Permeability Factor Release by Peripheral Blood Mononuclear Cells in Normal Subjects and in Patients with Minimal-Change Nephrotic Syndrome

By  

Nephron, Vol. 82, Iss. 1, 1999-04 ,pp. : 32-38

Karger

Access to resources Recommend Favorite

Interleukin-18 and Interleukin-12 Synergize to Stimulate the Production of Vascular Permeability Factor by T Lymphocytes in Normal Subjects and in Patients with Minimal-Change Nephrotic Syndrome

By  

Nephron, Vol. 85, Iss. 2, 2000-05 ,pp. : 127-133

Karger

Access to resources Recommend Favorite

Interleukin-4 Cooperates with Interleukin-10 to Inhibit Vascular Permeability Factor Release by Peripheral Blood Mononuclear Cells from Patients with Minimal-Change Nephrotic Syndrome

By  

American Journal of Nephrology, Vol. 19, Iss. 1, 1999-03 ,pp. : 21-27

Karger

Access to resources Recommend Favorite

Transforming Growth Factor-β in Renal Disease

By  

Kidney and Blood Pressure Research, Vol. 21, Iss. 1, 1998-06 ,pp. : 1-12

Karger

Access to resources Recommend Favorite

1,25–Dihydroxyvitamin D3 Stimulates Transforming Growth Factor–β1 Synthesis by Mouse Renal Proximal Tubular Cells

By  

Kidney and Blood Pressure Research, Vol. 22, Iss. 3, 1999-06 ,pp. : 99-105

Karger

Access to resources Recommend Favorite